Skip to main content
HALO
NASDAQ Life Sciences

Halozyme Posts $2.01 Q3 EPS as Royalty Engine Keeps Rolling

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$123.61
Mkt Cap
$13.956B
52W Low
$61.225
52W High
$134
52W Position info
102% above low
Off High info
7.8% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

HALO has more than doubled off its 52-week low of $61.225.

Summary

Halozyme reported third-quarter EPS of $2.01, a fresh quarterly print with no prior guidance figure in the record to grade it against, alongside third-quarter net income of $247M and revenue of $493M. The company enters this report on a strong run: Q2 2026 revenue hit a record $481M, up 48% year over year, with royalty revenue of $308M (+50%) driven by DARZALEX SC, VYVGART Hytrulo and Phesgo. It also carries fresh firepower after closing an upsized $1.5B convertible notes offering in September and a $1B buyback authorization. The October injunction halting Merck's Keytruda SC in multiple European markets adds a potential royalty tailwind, and the company raised its full year 2026 financial guidance to total revenue of $1.860-$1.925B, royalty revenue of $1.235-$1.255B, adjusted EBITDA of $1.240-$1.290B and non-GAAP diluted EPS of $8.75-$9.05.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Halozyme raised 2026 guidance: total revenue $1.860-$1.925B, royalty revenue $1.235-$1.255B, adjusted EBITDA $1.240-$1.290B, non-GAAP diluted EPS $8.75-$9.05.

At the time of this announcement, HALO was trading at $123.61 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14B. The 52-week trading range was $61.23 to $134.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

HALO - Latest Insights

HALO
Nov 19, 2026, 10:00 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $92.63
Real-time Price: $93.77 info
Change: +$1.14 (+1%) info
Market Cap: $10.607B info
HALO
Nov 06, 2026, 9:57 AM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $110.28
Real-time Price: $93.77 info
Change: -$16.51 (-15%) info
Market Cap: $10.607B info
HALO
Nov 05, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $114.34
Real-time Price: $93.77 info
Change: -$20.57 (-18%) info
Market Cap: $10.607B info
HALO
Oct 07, 2026, 8:30 AM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $110.00
Real-time Price: $93.77 info
Change: -$16.23 (-15%) info
Market Cap: $10.607B info
HALO
Oct 07, 2026, 1:19 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $110.00
Real-time Price: $93.77 info
Change: -$16.23 (-15%) info
Market Cap: $10.607B info